Parkinson’s is the fastest growing neurological condition in the world and affects around 153,000 people in the UK.

Scientists have identified the melatonin MT1 receptor as a key regulator of REM sleep, crucial for memory, dreaming, and ...

People with cognitive impairments have fewer gut microbes and less microbial diversity. That’s good news because we can ...

SGLT2 inhibitors, a class of diabetes drugs, may reduce the risk of Alzheimer’s, vascular dementia, and Parkinson’s disease, ...

At first, Jonel suspected she was experiencing symptoms of Parkinson’s disease as she had seen her father’s experience ...

A new study by scientists at Nottingham Trent University will use non-invasive techniques to investigate the targeted ...

A first-of-its-kind study will use ultrasound and light therapies to investigate targeted treatment of Alzheimer’s disease, ...

Parkinson’s disease is a neurodegenerative disorder characterized by the degeneration of dopamine-producing neurons, which are crucial for motor control and cognitive functions. As the worldwide ...

A new study suggests that the risk of developing dementia in Parkinson’s disease patients may be lower or occur later than previously reported. Researchers analyzed data from two large studies, ...

A woman from Chatham with Parkinson's disease is preparing to undertake a five-day trek along the Great Wall of China. Vivienne Hill, who's sixty, received the diagnosis a year ago. She is hoping ...

A man who has been living with Parkinson's disease for 20 years has described a new drug treatment as "life-altering". Rick Telford, 70, from Heaton in Newcastle, previously had to take about 20 ...